မာ့ခ် (6MK) Stock Price & News

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia

About မာ့ခ်

CEORobert M Davis

Employees၇.၄ သောင်း

Founded၁၈၉၁ ဇန် ၁

Headquarters-

Sector-

Websitemerck.com

Revenue

Net income

All values in USD	၂၀၂၅ စက်	၂၀၂၅ ဒီ	၂၀၂၆ မတ်	၂၀၂၆ ဇွန်
Revenue	ဋေ ၁.၇၃ ထ	ဋေ ၁.၆၄ ထ	ဋေ ၁.၆၃ ထ	ဋေ ၁.၆၆ ထ
Cost of goods sold	၃၇၄.၅၀ ဋေ	၄၂၉.၅၀ ဋေ	၃၈၇.၅၀ ဋေ	၄၁၂.၈၀ ဋေ
Cost of revenue	၃၇၄.၅၀ ဋေ	၄၂၉.၅၀ ဋေ	၃၈၇.၅၀ ဋေ	၄၁၂.၈၀ ဋေ
Research and development expenses	၄၀၀.၁၀ ဋေ	၃၉၉.၇၀ ဋေ	၃၅၅.၈၀ ဋေ	၉၇၄.၂၀ ဋေ
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	၂၄၈.၁၀ ဋေ	၂၇၃.၃၀ ဋေ	၂၅၆.၆၀ ဋေ	၂၇၇.၇၀ ဋေ
Operating expense	၆၄၈.၂၀ ဋေ	၆၇၃.၀၀ ဋေ	၆၁၂.၄၀ ဋေ	ဋေ ၁.၂၅ ထ
Total operating expenses	ဋေ ၁.၀၂ ထ	ဋေ ၁.၁၀ ထ	၉၉၉.၉၀ ဋေ	ဋေ ၁.၆၆ ထ
Operating income	၇၀၄.၉၀ ဋေ	၅၃၇.၅၀ ဋေ	၆၂၈.၇၀ ဋေ	-၄.၀၀ ကုဋေ
Other non operating income	-	၄.၁၀ ကုဋေ	၄.၂၀ ကုဋေ	၅.၉၀ ကုဋေ
EBT including unusual items	၆၇၄.၅၀ ဋေ	၃၄၂.၀၀ ဋေ	-၃၅၃.၄၀ ဋေ	-၆၈.၃၀ ကုဋေ
EBT excluding unusual items	၆၇၆.၂၀ ဋေ	၄၉၇.၅၀ ဋေ	၅၈၄.၇၀ ဋေ	-၅၀.၈၀ ကုဋေ
Income tax expense	၉၅.၈၀ ကုဋေ	၄၅.၈၀ ကုဋေ	၇၀.၉၀ ကုဋေ	၆၅.၄၀ ကုဋေ
Effective tax rate	၁၄.၂၀%	၁၃.၃၉%	-၂၀.၀၆%	-၉၅.၇၅%
Other operating expenses	-	-	-	-
Net income	၅၇၈.၅၀ ဋေ	၂၉၆.၃၀ ဋေ	-၄၂၄.၀၀ ဋေ	-၁၃၃.၅၀ ဋေ
Net profit margin	၃၃.၄၉%	၁၈.၀၇%	-၂၆.၀၃%	-၈.၀၄%
Earnings per share	၂.၅၈	၂.၀၄	-၁.၂၈	-၀.၁၃
Interest and investment income	၉.၆၀ ကုဋေ	၆.၉၀ ကုဋေ	၃.၅၀ ကုဋေ	၃.၅၀ ကုဋေ
Interest expense	-၃၂.၇၀ ကုဋေ	-၄၁.၁၀ ကုဋေ	-၄၇.၉၀ ကုဋေ	-၅၂.၅၀ ကုဋေ
Net interest expenses	-၂၃.၁၀ ကုဋေ	-၃၄.၂၀ ကုဋေ	-၄၄.၄၀ ကုဋေ	-၄၉.၀၀ ကုဋေ
Depreciation and amortization charges	-	-	-	-
EBITDA	၈၁၄.၇၀ ဋေ	၆၇၉.၃၀ ဋေ	၇၆၉.၁၀ ဋေ	၁၄၂.၈၀ ဋေ
Gain or loss from assets sale	-	-	-	-

Ask anything